TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-5.03%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.81B
AUM Growth
+$1.81B
(+20%)
Cap. Flow
+$415M
Cap. Flow
% of AUM
22.93%
Top 10 Holdings %
Top 10 Hldgs %
39.2%
Holding
208
New
25
Increased
77
Reduced
32
Closed
6
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$50.6M |
| 2 |
Galapagos
GLPG
|
$45.2M |
| 3 |
Kiniksa Pharmaceuticals
KNSA
|
$33.1M |
| 4 |
Spyre Therapeutics
SYRE
|
$33.1M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$24.3M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$10.6M |
| 2 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$7.23M |
| 3 |
GRAL
GRAIL, Inc. Common Stock
GRAL
|
$4.82M |
| 4 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$4.72M |
| 5 |
Seer Inc
SEER
|
$1.52M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Technology | 1.25% |
| 3 | Communication Services | 1.23% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Biogen
BIIB
$20.8B
| $4.79M | 0.27% |
35,000
| – | – |
|
77
Ionis Pharmaceuticals
IONS
$9.64B
| $4.53M | 0.25% |
150,000
| – | – |
|
78
CytomX Therapeutics
CTMX
$350M
| $4.27M | 0.24% |
6,717,825
-593,935
| -8% | -$378K |
|
79
Merus
MRUS
$5.04B
| $4.21M | 0.23% |
100,000
| – | – |
|
80
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $4.11M | 0.23% |
5,097,362
+1,447,362
| +40% | +$1.17M |
|
81
Janux Therapeutics
JANX
$1.38B
| $4.05M | 0.22% |
150,000
+100,000
| +200% | +$2.7M |
|
82
Cytokinetics
CYTK
$5.98B
| $4.02M | 0.22% |
100,000
| – | – |
|
|
CMPS
83
Compass Pathways
CMPS
$452M
| $4M | 0.22% |
1,400,000
+400,000
| +40% | +$1.14M |
|
84
TG Therapeutics
TGTX
$5.03B
| $3.94M | 0.22% |
100,000
| – | – |
|
85
Genmab
GMAB
$16.7B
| $3.92M | 0.22% |
200,000
+100,000
| +100% | +$1.96M |
|
86
Novavax
NVAX
$1.2B
| $3.85M | 0.21% |
600,000
| – | – |
|
87
Alexandria Real Estate Equities
ARE
$13.9B
| $3.7M | 0.2% |
40,000
| – | – |
|
88
Vera Therapeutics
VERA
$1.47B
| $3.6M | 0.2% |
+150,000
| New | +$3.6M |
|
89
Soleno Therapeutics
SLNO
$3.56B
| $3.57M | 0.2% |
50,000
| – | – |
|
90
Ventyx Biosciences
VTYX
$184M
| $3.57M | 0.2% |
3,100,000
| – | – |
|
91
Nuvalent
NUVL
$5.74B
| $3.55M | 0.2% |
50,000
| – | – |
|
92
Revolution Medicines
RVMD
$7.43B
| $3.54M | 0.2% |
100,000
| – | – |
|
93
Kezar Life Sciences
KZR
$28.5M
| $3.51M | 0.19% |
720,000
| – | – |
|
94
Biohaven
BHVN
$1.71B
| $3.37M | 0.19% |
140,000
| – | – |
|
95
Stoke Therapeutics
STOK
$1.08B
| $3.33M | 0.18% |
500,000
+200,000
| +67% | +$1.33M |
|
|
SWTX
96
DELISTED
SpringWorks Therapeutics
SWTX
| $3.28M | 0.18% |
74,265
| – | – |
|
97
Vir Biotechnology
VIR
$765M
| $3.24M | 0.18% |
+500,000
| New | +$3.24M |
|
|
THRD
98
DELISTED
Third Harmonic Bio
THRD
| $3.23M | 0.18% |
929,727
+779,727
| +520% | +$2.71M |
|
99
Precision BioSciences
DTIL
$59.5M
| $3.21M | 0.18% |
673,332
| – | – |
|
100
Black Diamond Therapeutics
BDTX
$164M
| $3.21M | 0.18% |
2,070,209
| – | – |
|